Japan's Terumo Said to Bid for Abbott's (ABT) Medical Device Business - Nikkei

September 29, 2016 1:42 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Japan's Terumo is looking to purchase Abbott's (NYSE: ABT) medical device business, according to Nikkei. Terumo bid for the cardiovascular device segment and operations, the report said. The deal could be valued at $1.47 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors

Add Your Comment